Get Integrated Data for Your Specialty and Interest Aresa
 
Category Select :
Items 1 ~ 20 of 25536, Page 1 of 1278
1. Mercks KEYTRUDA (pembrolizumab) Significantly Improved Overall Survival (OS) Compared to Chemotherapy in Patients with Advanced Esophageal or Esophagogastric Junction Carcinoma Whose Tumors Express PD-L1 (CPS 10) - 11/14/2018
 MERCK
  With Pivotal KEYNOTE-181 Trial Meeting Primary Endpoint of OS, KEYTRUDA Becomes the First Anti-PD-1 Therapy to Demonstrate a Survival Benefit for These Patients
2. Abbott Recommends Rejection of Below-Market Mini-Tender Offer by Baker Mills LLC - 11/14/2018
 Abbott
  ABBOTT PARK, Ill., Nov. 14, 2018 /PRNewswire/ --?Abbott (NYSE: ABT) received notice of an unsolicited mini-tender offer by Baker Mills LLC (Baker Mills) to purchase up to 60,000 Abbott common shares, representing approximately 0.003 percent of the company''''s outstanding shares. Baker Mills'''' offer price of $57.00 per share in cash is approximately 22 percent lower than the $72.79 closing price of Abbott common shares on Nov. 9, 2018, the last closing price prior to commencement of the offer.
3. AMA Adopts New Policies at 2018 Interim Meeting - 11/13/2018
 American Medical Association (AMA)
  The AMA voted to adopt new policies on emerging health care topics during the voting session of its Interim Meeting.
4. AMA Adopts Policy to Bolster Firearm Background Checks - 11/13/2018
 American Medical Association (AMA)
  AMA calls on states to strengthen their reporting of mental health records to NICS to help prevent firearm injuries and deaths.
5. AMA Expands Anti-tobacco Policies to Further Protect Youth - 11/13/2018
 American Medical Association (AMA)
  The AMA adopted policies encouraging the FDA to prohibit the use of flavoring agents in tobacco products, including electronic nicotine delivery systems.
6. AMA Advocates for Transparency in Food Labeling and Packaging - 11/13/2018
 American Medical Association (AMA)
  The AMA urges the FDA to develop front-of-package warning labels for foods that are high in added sugars based on the established recommended daily value.
7. FDA Approves Mercks KEYTRUDA (pembrolizumab) for the Treatment of Patients with Hepatocellular Carcinoma (HCC) Who Have Been Previously Treated with Sorafenib - 11/09/2018
 MERCK
  Approval Marks 14 th Indication for KEYTRUDA
8. Medtronic to Announce Financial Results for Its Second Quarter of Fiscal Year 2019 - 11/09/2018
 Medtronic
  DUBLIN - November 9, 2018 - Medtronic plc (NYSE:MDT) announced today that it will report financial results for the second quarter of fiscal year 2019 on Tuesday, November 20, 2018. A news release will be issued at approximately 5:45 a.m. Central Standard Time (CST) and will be available at http://newsroom.medtronic.com. The news release will include summary financial information for the company''s second quarter of fiscal year 2019, which ended on Friday, October 26, 2018.
9. New Data from Investigational Study of LENVIMA (lenvatinib) and KEYTRUDA (pembrolizumab) Combination in Three Different Tumor Types Presented at the Society for Immunotherapy of Cancers 33rd Annual Meeting - 11/09/2018
 MERCK
  First presentation of LENVIMA and KEYTRUDA combination data in patients with metastatic non-small cell lung cancer, metastatic melanoma and metastatic urothelial carcinoma from Study 111/KEYNOTE-146 New data support ongoing broad clinical program for LENVIMA and KEYTRUDA combination across multiple tumor types
10. Medtronic Begins Renal Denervation Study for High Blood Pressure Patients Prescribed Anti-Hypertensive Medication - 11/08/2018
 Medtronic
  FDA-Approved Study Furthers Medtronic Commitment to Generate Meaningful Clinical Evidence for Use of Renal Denervation to Treat Uncontrolled Hypertension
11. Cigarette Smoking Among U.S. Adults Lowest Ever Recorded: 14% in 2017 - 11/08/2018
 Centers for Disease Control and Prevention
  Cigarette smoking has reached the lowest level ever recorded among U.S. adults, according to new data published by the Centers for Disease Control and Prevention (CDC), the Food and Drug Administration (FDA), and the National Institutes of Healths National Cancer Institute (NCI). Still, about 47 million (1 in 5) U.S. adults used a tobacco product in 2017, and they used a variety of smoked, smokeless, and electronic tobacco products.
12. International Day of Radiology Recognizes Medical Imaging Contributions - 11/08/2018
 Radiological Society of North America
  OAK BROOK, Ill. (Nov. 8, 2018) ? Today is International Day of Radiology (IDoR), celebrated around the world in recognition of the remarkable contributions made by medical imaging to health care, and the role of radiology professionals in providing quality care to patients. The day is sponsored by the Radiological Society of North America (RSNA), the American College of Radiology (ACR) and the European Society of Radiology (ESR) and is observed by nearly 170 international radiology societies through public lectures, press events and other activities.
13. Early Phase 1 Data from Mercks Oncology Pipeline for Investigational Anti-LAG-3 Therapy (MK-4280) and Anti-TIGIT Therapy (MK-7684) to Be Presented at SITCs 33rd Annual Meeting - 11/07/2018
 MERCK
  With New Data, Merck Now has Presented Early Clinical Data for Six Investigational Oncology Pipeline Candidates Spanning Several Pathways
14. Medtronic Presents IN.PACT SFA Trial Five-Year Data and Total IN.PACT All-Subjects Analysis in VIVA Late Breaking Clinical Trials - 11/06/2018
 Medtronic
  (GLOBE NEWSWIRE via COMTEX) --New Data Continue to Reinforce IN.PACT Admiral DCB as a Durable, Frontline Option to Address Treatment Challenges in PAD
15. Artificial Intelligence Predicts Alzheimer''s Years Before Diagnosis - 11/06/2018
 Radiological Society of North America
  OAK BROOK, Ill. ? Artificial intelligence (AI) technology improves the ability of brain imaging to predict Alzheimer''s disease, according to a study published in the journal Radiology.
16. American Joint Replacement Registry (AJRR) Releases 2018 Annual Report - 11/02/2018
 American Academy of Orthopaedic Surgeons
  Data shows continuity of hip and arthroplasty trends, and the value of more complete information for early survival analysis of primary arthroplasty
17. Top stories: the appendix"s secret seeds, earthquake warnings, and a halted heart repair trial - 11/02/2018
 Science by Frankie Schembri
  We tend to ignore the appendix unless it gets inflamed and needs cutting out. But a new study suggests this enigmatic organ in the gut harbors a supply of a brain, damaging protein involved in Parkinson''s diseaseeven in healthy people.
18. AMA Applauds HHS for Revisions to Medicare E/M Policies - 11/01/2018
 American Medical Association (AMA)
  The AMA applauded HHS efforts to rein in documentation requirements that interfere with the patient-physician relationship.
19. Electrical spinal cord stimulation must preserve proprioception to enable locomotion in humans with spinal cord injury - 10/31/2018
 Nature Neuroscience (2018)
  The combination of spinal epidural stimulation and physical therapy is restoring walking function to people with spinal cord injury. With intensive rehabilitation, some participants are able to walk in their communities during stimulation and even regain control over previously paralyzed movement in the absence of stimulation.
20. FDA Approves Merck"s KEYTRUDA (pembrolizumab) in Combination with Carboplatin and Either Paclitaxel or Nab-Paclitaxel for the First-Line Treatment of Patients with Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC) - 10/30/2018
 MERCK
  Approval Based on Results of Phase 3 KEYNOTE-407 Trial, Which Demonstrated Superior Overall Survival with KEYTRUDA in Combination with Chemotherapy Compared to Chemotherapy Alone First Anti-PD-1 Approved for First-Line Treatment of Squamous NSCLC Regardless of PD-L1 Expression
<<  <  [1[2]  [3]  [4]  [5]  [6]  [7]  [8]  [9]  [10]  >  >>
 


Copyright ~2018 by Medisurf. All Rights Reserved Terms of Service Privacy Email : medalls@medalls.com